You searched for "Glaucoma-NET"
Glaucoma-NET: a novel way of improving glaucoma management in sub-Saharan Africa
Background Glaucoma is the second most common cause of blindness worldwide [1]. People with untreated glaucoma suffer from irreversible, progressive loss of sight. The disease is characterised by progressive loss of visual field, with pathological cupping of the optic disc...
Risk factors and untreated POAG
The authors examined 50 untreated open angle glaucoma patients to determine if there was an association between the level of glaucomatous damage and documented risk factors. In this study the authors measured the extent of morphologic and functional glaucomatous damage...
Reproducible OCT RNFL map in unilateral glaucoma
The aim of the study was to compare the reproducibility of the optical coherence tomography retinal nerve fibre layer (OCT RNFL) thickness map between glaucomatous and fellow normal eyes of unilateral glaucoma patients. The authors carried out a prospective case...BELKIN Vision is pleased to announce FDA clearance for its glaucoma laser, the Eagle device
BELKIN Vision, an innovator in ophthalmic medical solutions, is pleased to announce that the US Food and Drug Administration (FDA) has granted 510(k) clearance for its glaucoma laser, the Eagle device.The first virtual UKEGS conference will be held on Friday 27 November 2020
For the first time, the UK and Eire Glaucoma Society (UKEGS) 2020 conference will be hosted digitally in light of the pandemic.Cybersight: Using OCT as an Approach to Diagnose Glaucomatous and Other Optic Neuropathies
Clinically, the difference between glaucomatous and simple optic atrophy of other origins is not always clear. OCT with the ability to image and measure inner retinal layers in the macula and peripapillary area, with the measurement of rim atrophy, is...UKEGS Conference 2025
UKEGS (UK and Éire Glaucoma Society) Conference 2025
Glaucoma diagnosis with spectral-domain OCT of GCL and IPL
This is a prospective, cross-sectional, observational study by the New York Eye and Ear Infirmary, which recruited normal subjects and glaucoma patients with a range of visual field loss representing various degrees of glaucomatous optic neuropathy. A total of 69...Glaucoma UK offers up to £50,000 for the Open Call Research Award 2024
Glaucoma UK accepts applications for the Open Call Research Award 2024, which offers up to £50,000 in funding for glaucoma-related research. This award invites both clinical and non-clinical researchers who aim to enhance our understanding of glaucoma, and improve outcomes for people living with the disease.
Uveitic glaucoma
The purpose of this retrospective study from two tertiary Institutions in Israel over a period of 13 years, is to present the long-term outcomes of uveitic glaucoma and to identify risk factors for progression. The study included 34 patients (53...
Retinal vessel diameter in pseudoexfoliation
Pseudoexfolation (PEX) is characterised by deposition of fibrillary extracellular material on ocular and extraocular tissue. Studies have shown that deposition in vascular structures cause hypoxia and ischaemia. In the eye, a decrease in blood supply to the optic nerve can...
